Implementation of a Universal Cervical Length Screening Program for the Prevention of Preterm Birth

Abstract

Objective The objective of this article is to evaluate the implementation and acceptability of a universal cervical length (CL) screening program for prediction and prevention of preterm birth (PTB).

Study Design We performed a prospective observational study to evaluate the implementation and acceptability of a universal CL screening program. Between January 1, 2012, and December 31, 2012, women with singleton gestations, without a cerclage or prior spontaneous PTB, were offered transvaginal ultrasound (TVU) for CL between 18^0/7 and 23^6/7 weeks' gestation. Sonographers and medical staff received education before implementation. Intervention for a short CL was interpreted according to a standard protocol. On June 1, 2012, our program was modified from “opt-in” to “opt-out.” SPSS 20.0 (released 2011, IBM statistics for Windows version 20, IBM Corp., Armonk, NY) was used for analysis.

Results Over 12 months, 1,484 (87%) of 1,706 eligible women were offered CL screening, and 1,119 (75%) were actually screened. Women were more likely to accept CL screening if they were nulliparous versus multiparous (83 vs. 68%, p < 0.001) and if the sonographer was female versus male (83 vs. 42%, p < 0.001). Implementation of an “opt-out” protocol did not increase the overall number of women accepting CL screening compared with an “opt-in” approach (76 vs. 75%, p = 0.81)

Conclusion Universal CL screening can be feasibly implemented and is acceptable to most women.

Keywords

preterm birth - cervical length - universal screening - vaginal progesterone

Note

This article was presented at the SMFM Society for Maternal Fetal Medicine 33rd Annual Meeting, February 2013, San Francisco, CA.

• References

• 1 World Health Organization . March of Dimes; The Partnership for Maternal, Newborn & Child Health; Save the Children. Born Too Soon: The Global Action Report on Preterm Birth. Available at: http://www.who.int/pmnch/media/news/2012/preterm_birth_report/en/index.html . Accessed March 1, 2013
• 2 Berghella V, Rafael TJ, Szychowski JM, Rust OA, Owen J. Cerclage for short cervix on ultrasonography in women with singleton gestations and previous preterm birth: a meta-analysis. Obstet Gynecol 2011; 117 (3) 663-671
• 3 Society for Maternal-Fetal Medicine Publications Committee, with assistance of Vincenzo Berghella. Progesterone and preterm birth prevention: translating clinical trials data into clinical practice. Am J Obstet Gynecol 2012; 206 (5) 376-386
• 4 Committee on Practice Bulletins-Obstetrics. The American College of Obstetricians and Gynecologists. Practice bulletin no. 130: prediction and prevention of preterm birth. Obstet Gynecol 2012; 120 (4) 964-973
• 5 Iams JD, Goldenberg RL, Meis PJ , et al; National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. The length of the cervix and the risk of spontaneous premature delivery. N Engl J Med 1996; 334 (9) 567-572
• 6 Leung TN, Pang MW, Leung TY, Poon CF, Wong SM, Lau TK. Cervical length at 18-22 weeks of gestation for prediction of spontaneous preterm delivery in Hong Kong Chinese women. Ultrasound Obstet Gynecol 2005; 26 (7) 713-717
• 7 Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH ; Fetal Medicine Foundation Second Trimester Screening Group. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007; 357 (5) 462-469
• 8 Hassan SS, Romero R, Vidyadhari D , et al; PREGNANT Trial. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2011; 38 (1) 18-31
• 9 Werner EF, Han CS, Pettker CM , et al. Universal cervical-length screening to prevent preterm birth: a cost-effectiveness analysis. Ultrasound Obstet Gynecol 2011; 38 (1) 32-37
• 10 Cahill AG, Odibo AO, Caughey AB , et al. Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis. Am J Obstet Gynecol 2010; 202 (6) 548.e1-548.e8
• 11 Yudin MH, Moravac C, Shah RR. Influence of an “opt-out” test strategy and patient factors on human immunodeficiency virus screening in pregnancy. Obstet Gynecol 2007; 110 (1) 81-86
• 12 Cervical Length Education and Review (CLEAR) program. Available at: www.perinatalquality.com/CLEAR/deault.aspx . Accessed March 1, 2013
• 13 The Fetal Medicine Foundation. Online Education. Cervical assessment. Available at: http://www.fetalmedicine.com/fmf/online-education/05-cervical-assessment/ . Accessed May 13, 2013
• 14 Berghella V. Universal cervical length screening for prediction and prevention of preterm birth. Obstet Gynecol Surv 2012; 67 (10) 653-658